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Abstract
Background: Takotsubo cardiomyopathy is rare in pregnancy and is characterized by left ventricular dysfunction
with apical ballooning. This transient cardiac dysfunction may affect women of childbearing age in the antepartum,
intrapartum or postpartum period. Most patients respond well to medical management with resolution of cardiac
dysfunction within weeks.
Case presentation: A 35-year-old female in her second pregnancy presented with severe preeclampsia at 31 weeks
of gestation. She subsequently developed severe substernal chest pain and workup showed a stress induced
cardiomyopathy prior to her delivery via caesarean section. She had full recovery of her cardiac function by 12
weeks postpartum after medical management.
Conclusions: Stress induced cardiomyopathy, though rare, should be considered after acute myocardial infarction
has been ruled out in gravid females presenting with acute chest pain. Management should involve a
multidisciplinary team. Cardiac function recovery is common within 4 weeks although some patients may require
long term heart failure management.
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Background
Takotsubo cardiomyopathy (TCM) also known as stress
induced cardiomyopathy is characterized by new onset
left ventricular dysfunction with variable wall motion ab-
normalities in the absence of significant coronary artery
disease [1–3]. Cardiac function usually recovers spon-
taneously in most patients within days or weeks [4, 5].
The common triggers of TCM include emotional or psy-
chological stressors with a higher incidence seen in pa-
tients with preexisting psychiatric conditions [6].
However, up to 20% of affected patients have no identifi-
able stressors [1, 7]. Majority of TCM cases in pregnancy
are described in the peripartum period irrespective of
the mode of delivery [8–10] making it difficult to differ-
entiate TCM from peripartum cardiomyopathy [5].
In this article, we present a case of a 35-year-old fe-
male who presented with severe preeclampsia at 31
weeks of gestation and subsequently developed TCM
during her hospitalization. We further review the
current literature on stress-induced cardiomyopathy in
pregnancy.
Case report
A 35-year-old Indian female, para 1 + 0 gravida 2, was
admitted with severe preeclampsia at 31 weeks of gesta-
tion after complaints of anasarca for 1 week. She re-
ported normal fetal movements with no epigastric
discomfort, headaches or visual blurring. She had a
blood pressure of 190/110mmHg with a regular pulse
rate at 70 beats/minute palpable on all extremities. She
was afebrile at 36.7°C, had a respiratory rate of 18
breaths per minute and peripheral oxygen saturation of
99% on room air.
Six years prior, she had had severe preeclampsia and a
preterm delivery by caesarean section at 29 weeks of ges-
tation. The baby died of infant respiratory distress syn-
drome shortly after birth causing the patient significant
psychological distress requiring counselling. This made
her defer the possibility of a pregnancy for years sighting
psychological trauma.
This pregnancy, she presented in the first trimester for
antenatal care. Her blood pressure was 110/70 mmHg
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and antenatal profile was unremarkable: Hemoglobin
13.0 g/dl; Hepatitis-B surface Antigen, H.I.V. and Ven-
ereal Disease Research Laboratory (VDRL) were nega-
tive. Her blood group was O with positive Rhesus factor.
The dating scan confirmed a 12-week-old gestation and
she was placed on aspirin 75 mg throughout her preg-
nancy. Subsequent antenatal visits at 16, 20, 24, 28 and
30 weeks were uneventful with normal blood pressures.
An anomaly obstetric scan at 20 weeks gestation showed
no fetal anomalies with subsequent growth scans at 24
and 28 weeks showing normal growth with normal um-
bilical and middle cerebral artery doppler flows.
On admission, she had macro albuminuria with elevated
urine albumin creatinine ratio of 422mg/mmol. Her
hemoglobin was 12.1 g/dl and the platelet count was
194,000/ml. The renal and liver functions were normal.
She was started on intravenous (IV) magnesium
sulphate infusion as per the Zuspan regime [11] (4 g slow
IV bolus followed by 1 g/hour for 24 h) for maternal seiz-
ure prophylaxis and fetal neuro-protection [12]. She re-
ceived multiple push doses of IV hydralazine for blood
pressure control and was eventually placed on hydralazine
infusion at 1mg/hour. In addition, she received oral ni-
fedipine and oral alpha methyldopa. Two doses of beta-
methasone 12mg were administered intramuscularly 24 h
apart for fetal lung maturation. She also received low mo-
lecular weight heparin (LMWH) for thromboprophylaxis
and the total fluid intake was maintained at 80ml/hr. to
minimize the risk of pulmonary oedema.
Thirty hours post-admission, she developed worsening
orthopnea with severe sub sternal left sided chest pain
radiating to the left axilla without symptoms of diaphor-
esis, nausea or vomiting. Her blood pressure was 138/82
mmHg, pulse rate of 64 beats per minute, and peripheral
oxygen saturation via pulse oximetry was 99% on room
air. A chest x-ray revealed no features of pulmonary
edema while an electrocardiogram (ECG) revealed a
sinus rhythm with ST elevation in the anteroseptal leads
(V1–4), Q waves in the septal leads (V1–2) and peaked
T waves in V2–4 indicating an acute anteroseptal
ST-Elevation Myocardial Infarction (STEMI) (Fig. 1). A
transthoracic echocardiogram showed wall motion ab-
normalities with interventricular septum and anterior
wall hypokinesia. The left ventricle (LV) was dilated with
an ejection fraction of 48% (Fig. 2). The right ventricular
size was normal whereas the peak pulmonary arterial pres-
sure was elevated at 50mm/Hg. Lower extremity dopplers
revealed no venous thrombus while an assay of cardiac en-
zymes revealed elevated Troponin I levels of 0.51 ng/ml
(normal ≤0.04 ng/ml) and Creatinine Kinase -MB (CK-MB)
levels of 54 IU/l (reference range 5–25 IU/l).
Fetal assessment ultrasound done on day 2 of admission
revealed an abnormal cerebroplacental ratio (CPR) of 0.57
necessitating delivery by caesarean section. The infant
weighed 1 .5kg with Apgar score of 9 at 1 min and 10 at 5
min. Left cardiac catheterization was subsequently done
on day 3, approximately 18 h after the last dose of LMWH
and showed left ventricular apical ballooning with no evi-
dence of atherosclerosis in the coronaries.
The LMWH thromboprophylaxis (0 .5mg/kg once
daily) was restarted 12 h post-delivery for one week. The
blood pressure was controlled with amlodipine (10 mg
Fig. 1 ECG trace showing ST elevation in the antero-septal leads (V1–4), Q waves in the septal leads (V1–2) and peaked T waves in V2–4)
indicating an acute antero-septal ST-Elevation Myocardial Infarction
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once daily). Postpartum, she remained normotensive and
anti-hypertensive medication was stopped after 6 weeks.
Cardiac injury biomarkers normalized by the 10th post-
partum day. The ECG done at 6 weeks postpartum
showed frontal QRS complex of + 100 degrees with QS
complexes from V1 to V3 consistent with recent
antero-septal myocardial infarction (Fig. 3) while that
done 6 weeks later showed no significant abnormalities
(Fig. 4). The echocardiogram at 3 months post-delivery
revealed normal cardiac chambers with no regional wall
motion abnormalities with a left ventricle ejection frac-
tion of 65%.
Discussion
Takotsubo cardiomyopathy (TCM) is a rare life-threat-
ening illness that can affect pregnant women. It should
be considered a cardiac emergency as it mimics myo-
cardial infarction, peripartum cardiomyopathy, acute
myocarditis, and dilated cardiomyopathy and is a diag-
nosis of exclusion. Takotsubo cardiomyopathy (TCM)
typically presents with acute retrosternal chest pain,
palpitations and diaphoresis [5]. Affected patients may
also have symptoms of left heart failure such as parox-
ysmal nocturnal dyspnea, orthopnea and dyspnea [1].
Fig. 2 Transthoracic echocardiography showing apical ballooning of the left ventricle (LV: Left Ventricle; RV: Right Ventricle; LA: Left Atrium; RA:
Right Atrium)
Fig. 3 ECG trace showing frontal QRS complex of + 100 degrees. She had QS complexes from V1 to V3 consistent with prior antero-septal
myocardial ischemia
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The common triggers of TCM include psychosocial
stressors with greater occurrence in those with premorbid
psychiatric illnesses [6, 13]. Our patient had a history of
depressive illness due to a previous adverse pregnancy
outcome which may have predisposed her to TCM. In
addition, it is possible that the severe preeclampsia caused
an acute elevation of blood pressure from the baseline
triggering TCM. Increased afterload from hypertension
may cause a demand-supply mismatch leading to a type 2
non- ST-elevation myocardial infarction (NSTEMI) [14].
Diagnostic evaluation of TCM includes an electrocar-
diogram (ECG), cardiac biomarkers, echocardiography
and left heart angiography. The ECG abnormalities com-
monly encountered include ST segment elevation in the
anterior and precordial leads with some having ST seg-
ment depression [15, 16]. A few patients may have QT
interval prolongation, T wave inversion, abnormal Q
waves and non-specific abnormalities [15]. The majority
of patients will have elevated cardiac troponin levels
with normal to mildly elevated creatinine kinase. The
natriuretic peptides (brain natriuretic peptide (BNP) and
pro-BNP) may be elevated in up to 83% of cases
indicating ventricular strain, though to a lesser extent
than that seen in acute myocarditis [16].
The typical findings on transthoracic echocardiog-
raphy include a large area of regional wall motion akin-
esia of the LV extending beyond the territory of a single
coronary artery [17]. There is apical ballooning of the
LV with normal basal contractility. The LV ejection frac-
tion is often reduced ranging from 20 to 49% [18]. In
addition, there may be mitral regurgitation with or with-
out a systolic anterior motion of the anterior leaflet [17].
The diagnosis of TCM is based on the Mayo clinic
diagnostic criteria [1]. This includes presence of transi-
ent akinesis, hypokinesis or dyskinesis of the left ven-
tricle with or without apical involvement; this regional
ventricular wall motion abnormality extends beyond a
single epicardial vascular perfusion territory. Further
there is absence of obstructive coronary disease or
angiographic evidence of acute plaque rupture. The pa-
tient may also have ECG abnormalities (such as
ST-segment elevation with or without T-wave inversion)
or moderately elevated cardiac troponin levels. Lastly,
myocarditis and phaechromocytoma need to be excluded
Fig. 4 Normal ECG trace following recovery from cardiomyopathy
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[1, 16]. Our patient had transient ECG abnormalities
and no angiographic evidence of acute plaque rupture or
vessel occlusion fulfilling the Mayo criteria for TCM.
Up to 25% of TCM cases may develop Left Ventricular
Outflow Tract (LVOT) obstruction due to the increased
contractility of the base of the heart [18, 19]. Prompt diag-
nosis by use of echocardiography and timely management
results in outcomes comparable to those without LVOT
[20]. The detection of LVOT obstruction is important as
the patients usually present with hypotension and the use
of ionotropic agents may increase the intraventricular
pressure gradient and induce cardiogenic shock [18].
Most patients recover normal cardiac function within
4 to 8 weeks [5, 16]. Our patient had resolution of heart
failure symptoms with full recovery by 12 weeks
post-delivery. Care of these patients is directed at man-
aging their symptoms and medical cardiac optimization
with diuretics, angiotensin-converting enzyme inhibitors
and beta blockers. Due to association with fetal growth
restriction, if on beta blockers, there is need to schedule
ultrasounds for fetal growth every 4 weeks.
The resolution of physical or emotional stress usually
results in rapid resolution of symptoms though some pa-
tients may develop acute complications such as acute
heart failure and cardiogenic shock requiring coronary
cardiac unit admission and need for invasive techniques
such as intra-aortic balloon pump and cardiopulmonary
support [10].
The decision on the timing and mode of delivery
should be guided by obstetrical reasons. It should in-
volve a multidisciplinary team of cardiologists, obstetri-
cians, neonatologists and psychologists.
Recurrence of TCM in premenopausal women is rare
[21]. Close follow up upon discharge is required as some
patients may deteriorate and develop major adverse car-
diac and cerebrovascular events [1].
In conclusion, TCM is a rare cardiac condition espe-
cially in pregnancy. Management challenges for ongoing
pregnancies are crowded by safety concerns of the drugs
used for managing acute myocardial infarction. Longitu-
dinal studies are needed to evaluate the reproductive
history of women with TCM and further assess its asso-
ciation with preeclampsia. However, we strongly advo-
cate for a multidisciplinary approach in order to
optimize outcomes for the mother and child.
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